| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |